Ordering EYLEA

EYLEA4U logo

Authorized Distributors

EYLEA is available through a number of different sources. Contact one of our Authorized Distributors listed below to order EYLEA and receive it by the next business day.*

Regeneron does not recommend the use of any particular listed distributor. Subject to distributor qualification.

*Orders received prior to 7 PM Eastern Time Monday–Thursday are typically processed on the same day and scheduled for delivery the next business day. Order received on Friday will typically be delivered the following Monday.

Specialty pharmacy providers

As an option, or if instructed by the payer, EYLEA may be obtained through our network of specialty pharmacy providers.

Regeneron does not recommend the use of any particular listed specialty pharmacy.

Discount

A wholesale acquisition cost (WAC)
1.1% discount on EYLEA is in effect

Cost per 2 mg/0.05 mL single-use EYLEA vial. Current WAC $1,850. With 1.1% discount based on QAC $1,829.65, $20.35 discount.

The discount is available to community-based physicians in freestanding, physician-owned solo or group practices who are treating patients on an outpatient basis and who purchase EYLEA directly from the Authorized Distributors listed above. This discount applies only to eligible purchasers ordering from an Authorized Distributor.

The discount is intended to constitute a discount as such term is defined in 42 U.S.C. § 1320a-7(b)(3) and 42 C.F.R. § 1001.952(h). As such, it must be reported by any eligible purchaser in any costs claimed or charges made to any federal healthcare program, including Medicare and Medicaid.

This discount for EYLEA® (aflibercept) Injection is available to eligible community-based physicians in freestanding, physician-owned solo or group practices who are treating patients on an outpatient basis and who purchase EYLEA directly from participating authorized distributors ("Eligible Community Physicians") in accordance with the following terms:*

Requires Health Industry Number (HIN)
The discount is a flat off-invoice discount based on the current EYLEA WAC only for Eligible Community Physicians with a valid practice HIN.

HIN is a unique ID for identifying healthcare trade partners, managed by the Health Industry Business Communications Council (HIBCC). If you do not have an HIN or are not sure if you have an HIN, contact your distributor for assistance.

You may also register for a HIN through HIBCC:
Online:
http://www.hibcc.org/hin-system/apply-for-a-hin/
E-mail:
info@hibcc.org

No Enrollment
The discount is not subject to any enrollment requirements.

Applies to All Eligible Purchases
The discount will apply to all purchases made by Eligible Community Physicians through a participating authorized distributor.

Only Eligible Community Physicians
The discount does not apply to hospitals, specialty pharmacies, retail pharmacies, compounding pharmacies, distributors, wholesalers, Federal government, Department of Defense, Indian Health Services, Veteran's Affairs, local governments, group purchasing organizations, managed care organizations, home care providers, long term care providers, donation accounts, pharmaceutical manufacturers, outside research organizations or veterinary providers.

Effective Date of Discount
The discount is effective January 12, 2017.

*Terms and availability are subject to change at Regeneron's discretion.

Please note that participating physicians have an obligation to comply with all retention, disclosure and reporting requirements regarding the value of any discounts or price concessions paid or received, pursuant to 42 U.S.C. § 1320a-7(b)(3) and 42 C.F.R. § 1001.952(h) and all other applicable federal and state laws and regulations. As such, it must be reported by any Eligible Community Physician in any costs claimed or charges made to any federal health care program, including Medicare and Medicaid.

Have a question about the discount through distributors for EYLEA?
We're here for you. Contact EYLEA4U® at 1-855-EYLEA4U (1-855-395-3248), Option 5, Monday–Friday 9 AM–8 PM Eastern Time.

Returns

In the event EYLEA is rendered unusable after purchase, product may be returned to Regeneron and replaced in certain circumstances. Returns are subject to adherence to Regeneron policies and procedures regarding the return of product and Regeneron’s right, at its sole discretion, to deny replacement when misuse is suspected. All product should be returned as a condition of replacement.‡,§

Call EYLEA4U at 1-855-EYLEA4U (1-855-395-3248), Option 3, to obtain the appropriate forms and list of required documents


If vial is broken
Submit pictures
documenting the damage.


If vial is intact
Return to the address
provided by EYLEA4U.

  • Subject to certain exceptions in accordance with Regeneron policy.
  • §Broken vial(s) do not have to be returned, but pictures documenting the damage should be submitted.

Product return procedure

  1. Contact EYLEA4U, 1-855-EYLEA4U (1-855-395-3248) and select Option 3
  2. Complete the Return Product Eligibility Certification form in its entirety and return with the following:
    • a. Proof of Purchase for units being returned
    • b. In the case of broken vial(s), pictures documenting the damage
  3. Completed forms and supporting documents may be faxed to (615) 827-0164 or emailed to return@regeneron.com
  4. Hold/quarantine the product to be returned and follow instructions in product retrieval kit
  5. Once approved, replacement product ships within 1 business day of approval

For returns of expired product or product damaged in shipment, contact your distributor for return. For product complaints, please call EYLEA4U at 1-855-EYLEA4U (1-855-395-3248), Option 3.

ICD-10 code finder

Use the interactive code finder to quickly find the current ICD-10 codes for EYLEA. To begin, simply answer the following short questions.

The coding information discussed here is provided for informational purposes only, is subject to change, and should not be construed as legal advice. The codes listed here may not apply to all patients or to all health plans; providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect the services and products furnished to a specific patient.

For which indication is EYLEA being administered?

  • Wet Age-related Macular Degeneration
  • Diabetic Macular Edema (DME)
  • Diabetic Retinopathy in Patients with DME
  • Macular Edema following Central Retinal Vein Occlusion
  • Macular Edema following Branch Retinal Vein Occlusion
{{f.FileSize}}mb
{{DownloadFormModel.OutputFileName}}.zip  {{DownloadFormModel.DownloadSize}} MB

Patient brochures

Provide your patients more information on their indication, EYLEA, and the support available through EYLEA4U.

Wet Age-related Macular Degeneration 0.3mb
Diabetic Macular Edema (DME)/Diabetic Retinopathy in DME 0.3mb
Macular Edema following Retinal Vein Occlusion 0.3mb
Wet Age-related Macular Degeneration (Spanish) 1.2mb
Diabetic Macular Edema (DME)/Diabetic Retinopathy in DME (Spanish) 1.2mb
Macular Edema following Retinal Vein Occlusion (Spanish) 1.2mb
Wet Age-related Macular Degeneration (Chinese Simplified) 1.2mb
Diabetic Macular Edema (DME)/Diabetic Retinopathy in DME (Chinese Simplified) 1.2mb
Macular Edema following Retinal Vein Occlusion (Chinese Simplified) 1.2mb
Wet Age-related Macular Degeneration (Chinese Traditional) 1.2mb
Diabetic Macular Edema (DME)/Diabetic Retinopathy in DME (Chinese Traditional) 1.2mb
Macular Edema following Retinal Vein Occlusion (Chinese Traditional) 1.2mb
Diabetic Macular Edema (DME)/Diabetic Retinopathy in DME (Creole) 2.0mb
Wet Age-related Macular Degeneration (Korean) 1.2mb
Diabetic Macular Edema (DME)/Diabetic Retinopathy in DME (Korean) 1.2mb
Macular Edema following Retinal Vein Occlusion (Korean) 1.2mb
Wet Age-related Macular Degeneration (Russian) 1.2mb
Diabetic Macular Edema (DME)/Diabetic Retinopathy in DME (Russian) 1.2mb
Macular Edema following Retinal Vein Occlusion (Russian) 1.2mb
Wet Age-related Macular Degeneration (Vietnamese) 1.2mb
Diabetic Macular Edema (DME)/Diabetic Retinopathy in DME (Vietnamese) 1.2mb
Macular Edema following Retinal Vein Occlusion (Vietnamese) 1.2mb

EYLEA4U Patient Brochure 1.2mb

EYLEA4U logo

EYLEA4U e-Portal

Your one-stop, online destination for reimbursement and patient support.

  • Requires registration and e-signature setup.
Reimbursement Support

Get help navigating the reimbursement process. Find enrollment forms, sample appeal letters, and more.

See the details
Patient Support

We're committed to help ensure your eligible patients have access to EYLEA regardless of insurance or coverage.

Find support
News

Keep up to date on current EYLEA clinical information, events, and more.

Read the latest
Important Safety Information and Indications
  • EYLEA® (aflibercept) Injection is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipients in EYLEA.
Important Safety Information Important Prescribing Information

EYLEA® (aflibercept) Injection is indicated for the treatment of patients with

Please see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The information provided in this site is intended only for healthcare professionals in the United States. The products discussed herein may have different product labeling in different countries.